Obesity and insulin resistance
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Part of HELIUS study and has given permission to be approached for new studies - Stable body weigh (
Exclusion criteria
Exclusion criteria: - Use of corticosteroids, antibiotics and other immunomodulating medication in last 3 months - current XTC, amphetamine, nicotine or cocaïne abuse - Alcohol abuse (>3 units per day) - Contraindication for MRI (pregnancy, neurological illness, malignancy, history of major heart disease, history of major renal disease, breastfeeding, paecmaker and metals contraindicated for MRI present in the body). - Expected prolonged compromised immunity (due to recent cytotoxic chemotherapy or HIV infection with a CD4 count
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Postprandial plasma SCFA including acetate levels after a standardized mixed meal test - Intestinal microbiota composition (morning stool samples) | — |
Secondary
| Measure | Time frame |
|---|---|
| - CNS (fMRI) responses to food pictures. The primary outcome is the difference in BOLD signal, i.e. in CNS activation in predefined regions (insula, striatum, amygdala, OFC and hypothalamus) in response to viewing food pictures or consuming actual food - Postprandial plasma glucose and insulin levels - Fasting plasma SCFA, glucose and insulin levels at baseline - Energy metabolism, measured by resting energy expenditure (REE) - Baseline physical activity energy expenditure (PAEE) - Dietary intake (https://mijn.voedingscentrum.nl/nl/eetmeter), weight and body composition (Body Impedance Analysis, BIA). - Subjective appetite sensations and food intake (VAS questionnaires) | — |
Countries
Netherlands